Cellular Biomedicine Group Inc Asset Turnover Ratio (CBMG), as of third quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cellular Biomedicine Group Inc   (NASDAQ: CBMG)
 

Cellular Biomedicine Group Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cellular Biomedicine Group Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.02 in the third quarter (Sep 30 2020)

Within sector 56 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2020, to 4208, from total ranking in the second quarter 2020 at 4256.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CBMG Asset Turnover Ratio (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Asset Change -25.92 % -48.08 % -29.22 % -10.65 % -0.9 %
Y / Y Revenue Change -87.66 % -90.13 % 2393.28 % 1031.04 % 271.52 %
Asset Turnover Ratio (TTM) 0.02 0.02 0.03 0.02 0.01
CBMG's Total Ranking # 4208 # 4256 # 4225 # 4833 # 4387
Seq. Asset Change 27.86 % -28.86 % 4.89 % -22.35 % -10.4 %
Seq. Revenue Change -74.07 % -89.86 % 322.6 % 11.08 % -79.27 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 57
Healthcare Sector # 590
Overall Market # 4208

Asset Turnover Ratio Statistics
High Average Low
0.12 0.02 -0.03
(Mar 31 2014)   (Jun 30 2015)




CBMG Company Profile • Back to CBMG Efficiency Comparisons • Compare CBMG Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2020 Assets at quarter ending Sep 30 2020
Albireo Pharma inc   0.06 $ 12.023  Millions$ 212.177  Millions
Alpine Immune Sciences Inc   0.05 $ 4.587  Millions$ 90.167  Millions
Wave Life Sciences Ltd   0.05 $ 13.038  Millions$ 259.208  Millions
Dyadic International Inc   0.05 $ 1.689  Millions$ 34.579  Millions
Concert Pharmaceuticals Inc   0.05 $ 7.908  Millions$ 162.529  Millions
Eton Pharmaceuticals Inc   0.05 $ 0.705  Millions$ 15.067  Millions
Cocrystal Pharma Inc   0.05 $ 1.906  Millions$ 41.267  Millions
Zymeworks Inc   0.05 $ 25.148  Millions$ 545.839  Millions
Biocorrx Inc   0.05 $ 0.163  Millions$ 3.569  Millions
Nabriva Therapeutics Plc  0.05 $ 2.900  Millions$ 64.234  Millions
Igc Pharma Inc   0.04 $ 1.311  Millions$ 29.524  Millions
Cue Biopharma Inc   0.04 $ 3.728  Millions$ 85.056  Millions
Ainos Inc   0.04 $ 0.018  Millions$ 0.429  Millions
Petvivo Holdings Inc   0.04 $ 0.026  Millions$ 0.630  Millions
Alector Inc   0.04 $ 22.246  Millions$ 536.115  Millions
Edesa Biotech Inc   0.04 $ 0.329  Millions$ 8.102  Millions
Silo Pharma Inc  0.04 $ 0.059  Millions$ 1.474  Millions
Fate Therapeutics Inc   0.04 $ 18.340  Millions$ 476.050  Millions
Checkpoint Therapeutics inc   0.04 $ 1.067  Millions$ 28.876  Millions
Biocardia Inc   0.04 $ 0.313  Millions$ 8.673  Millions
Sintx Technologies Inc   0.04 $ 0.729  Millions$ 20.432  Millions
Ardelyx inc   0.04 $ 8.012  Millions$ 227.751  Millions
Asensus Surgical Inc   0.03 $ 2.756  Millions$ 78.782  Millions
Rafael Holdings Inc  0.03 $ 4.753  Millions$ 137.635  Millions
Beyond Air Inc   0.03 $ 0.737  Millions$ 22.052  Millions
Denali Therapeutics Inc   0.03 $ 23.516  Millions$ 741.685  Millions
Infinity Pharmaceuticals Inc   0.03 $ 1.591  Millions$ 50.431  Millions
Epizyme Inc.  0.03 $ 11.681  Millions$ 421.341  Millions
Ibio inc   0.03 $ 1.940  Millions$ 71.062  Millions
Cyclerion Therapeutics Inc   0.02 $ 3.644  Millions$ 146.487  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.